2. Blanchette CM, Dalal AA, Mapel D. Changes in COPD demographics and costs over 20 years. J Med Econ 2012;15:1176–1182.
4. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM,
et al. 17 International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741–750.
5. Landis SH, Muellerova H, Mannino DM, Menezes AM, Han MK, van der Molen T,
et al. Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013. Int J Chron Obstruct Pulmon Dis 2014;9:597–611.
http://doi.org/10.2147/COPD.S61854.
6. Janus ED, Phillips NT, Carrell RW. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet 1985;1:152–154.
9. Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damas JK,
et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J 2010;35:540–548.
13. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR,
et al. Differential gene 18 and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012;7:562–578.
16. Hwang D, Rust AG, Ramsey S, Smith JJ, Leslie DM, Weston AD,
et al. A data integration methodology for systems biology. Proc Natl Acad Sci U S A 2005;102:17296–17301.
21. Liu Z, Hu J. Mislocalization-related disease gene discovery using gene expression based computational protein localization prediction. Methods 2016;93:119–127.
22. Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A,
et al. Proteomics: tissue-based map of the human proteome. Science 2015;347:1260419.
23. Reshef DN, Reshef YA, Finucane HK, Grossman SR, McVean G, Turnbaugh PJ,
et al. 19 Detecting novel associations in large data sets. Science 2011;334:1518–1524.
26. Duvoix A, Dickens J, Haq I, Mannino D, Miller B, Tal-Singer R,
et al. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax 2013;68:670–676.
27. Hacievliyagil SS, Mutlu LC, Temel I. Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers. Niger J Clin Pract 2013;16:76–81.
28. Saha S, Doe C, Mistry V, Siddiqui S, Parker D, Sleeman M,
et al. Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD. Thorax 2009;64:671–676.
34. Garcia-Nunez M, Millares L, Pomares X, Ferrari R, Perez-Brocal V, Gallego M,
et al. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease. J Clin Microbiol 2014;52:4217–4223.
35. You S, Yoo SA, Choi S, Kim JY, Park SJ, Ji JD,
et al. Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach. Proc Natl Acad Sci U S A 2014;111:550–555.
36. Wiegman CH, Michaeloudes C, Haji G, Narang P, Clarke CJ, Russell KE,
et al. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 2015;136:769–780.
37. Singh B, Parsaik AK, Mielke MM, Roberts RO, Scanlon PD, Geda YE,
et al. Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging. Mayo Clin Proc 2013;88:1222–1230.